These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31629628)

  • 1. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    Enocsson H; Wirestam L; Dahle C; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma AA; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; van Vollenhoven RF; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken CA; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Autoimmun; 2020 Jan; 106():102340. PubMed ID: 31629628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Bruce IN; O'Keeffe AG; Farewell V; Hanly JG; Manzi S; Su L; Gladman DD; Bae SC; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcón GS; Fessler BJ; Fortin PR; Petri M; Steinsson K; Dooley MA; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Urowitz MB
    Ann Rheum Dis; 2015 Sep; 74(9):1706-13. PubMed ID: 24834926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
    Legge A; Kirkland S; Rockwood K; Andreou P; Bae SC; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin PR; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcón GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
    Arthritis Rheumatol; 2020 Apr; 72(4):658-666. PubMed ID: 31631584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?
    Enocsson H; Sjöwall C; Wetterö J
    Clin Chim Acta; 2015 Apr; 444():234-41. PubMed ID: 25704300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus.
    Lima K; Legge A; Hanly JG; Lee J; Song J; Chung A; Ramsey-Goldman R
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):578-584. PubMed ID: 34590445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients.
    Pitta AC; Silva CA; Insfrán CE; Pasoto SG; Trindade VC; Novak GV; Sakamoto AP; Terreri MT; Pereira RM; Magalhães CS; Fonseca AR; Islabão AG; Assad AP; Buscatti IM; Elias AM; Piotto DP; Ferriani VP; Carvalho LM; Rabelo Junior CN; Marini R; Sztajnbok FR; Sacchetti SB; Bica BE; Moraes AJ; Robazzi TC; Lotufo S; Cavalcanti AS; Naka EN; Carneiro-Sampaio M; Bonfá E; Aikawa NE;
    Lupus; 2021 Dec; 30(14):2286-2291. PubMed ID: 34689652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.
    Zaitoon YA; Shehab AA; Mohamed NA; Morad CS; Yassine EM
    Egypt J Immunol; 2018 Jan; 25(1):35-43. PubMed ID: 30242996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort.
    Elera-Fitzcarrald C; Gamboa-Cárdenas RV; Reatégui-Sokolova C; Pimentel-Quiroz V; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2022 Nov; 31(13):1666-1670. PubMed ID: 36165429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.
    Frodlund M; Reid S; Wetterö J; Dahlström Ö; Sjöwall C; Leonard D
    Lupus; 2019 Sep; 28(10):1261-1272. PubMed ID: 31296137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    Legge A; Doucette S; Hanly JG
    J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus.
    Ugarte-Gil MF; Dubey J; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):585-589. PubMed ID: 35255194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
    Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A
    Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.